INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

LYCALycia Therapeutics, Inc.

CIK 0001806540

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells1 / 0
Max Insider Score32
Connections17with evidence

LYCA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
VP
Venrock Healthcare Capital Partners III, L.P.10% Owner
LYCALycia Therapeutics, Inc.
Open-market purchase
BUY$224K
8,305 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    VHCP Co-Investment Holdings III, LLC10% Owner · Nov 4, 2026
  • ← Insider ofevidence
    VHCP Management III, LLC10% Owner · Nov 4, 2026
  • ← Insider ofevidence
    Venrock Healthcare Capital Partners EG, L.P.10% Owner · Nov 4, 2026
24
SS
Staben StevenChief Scientific Officer, 10% Owner
LYCALycia Therapeutics, Inc.
Grant or award
A
—
110.9K sh
Aug 11, 2026
Oct 26, 2026
traded Aug 11, 2026
+76d
SEC FORM 4

Evidence

24
BA
Bachrodt AmyChief Financial Officer, 10% Owner
LYCALycia Therapeutics, Inc.
Grant or award
A—
399.7K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC FORM 4

Evidence

24
TW
Trombley Aetna WunDirector, President and CEO, 10% Owner
LYCALycia Therapeutics, Inc.
Grant or award
A—
443.6K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC FORM 4

Evidence

24
HJ
Henderson JaneDirector
LYCALycia Therapeutics, Inc.
Grant or award
A—
57.7K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC FORM 4

Evidence

24
TS
Touami SofiaChief Business Officer
LYCALycia Therapeutics, Inc.
Grant or award
A—
68.8K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC FORM 4

Evidence

24
FL
Fischer LaurentDirector
LYCALycia Therapeutics, Inc.
Grant or award
A—
13.3K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC FORM 4

Evidence

9
FL
Fischer LaurentDirector
LYCALycia Therapeutics, Inc.
Grant or award
A—
20.0K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC FORM 4

Evidence

24
LH
Lee Chin HyokChief Medical Officer, 10% Owner
LYCALycia Therapeutics, Inc.
Grant or award
A—
73.2K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC FORM 4

Evidence

9
HJ
Henderson JaneDirector
LYCALycia Therapeutics, Inc.
Grant or award
A—
20.0K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    VHCP Management EG, LLC10% Owner · Nov 4, 2026
  • ← Insider ofevidence
    Venrock Healthcare Capital Partners XP, L.P.10% Owner · Nov 4, 2026
  • ← Insider ofevidence
    VHCP Management XP, LLC10% Owner · Nov 4, 2026
  • ← Insider ofevidence
    Koh Bong Y10% Owner · Nov 4, 2026
  • ← Insider ofevidence
    Venrock Healthcare Capital Partners III, L.P.10% Owner · Nov 4, 2026
  • ← Insider ofevidence
    Shah Nimish P10% Owner · Nov 4, 2026
  • ← Insider ofevidence
    Staben StevenChief Scientific Officer, 10% Owner · Oct 26, 2026
  • ← Insider ofevidence
    Bachrodt AmyChief Financial Officer, 10% Owner · Oct 26, 2026
  • ← Insider ofevidence
    Lee Chin HyokChief Medical Officer, 10% Owner · Oct 26, 2026
  • ← Insider ofevidence
    Trombley Aetna WunDirector, President and CEO, 10% Owner · Oct 26, 2026
  • ← Insider ofevidence
    Henderson JaneDirector · Oct 26, 2026
  • ← Insider ofevidence
    Fischer LaurentDirector · Oct 26, 2026
  • ← Insider ofevidence
    Touami SofiaChief Business Officer · Oct 26, 2026